Prognostic models incorporating clinical and pathological parameters might assist clinicians in counselling and surveillance of patients following surgical resection of renal cell carcinoma (RCC). Variability exists in the risk classification of individual patients in each model as well as the performance of each model in different RCC subtypes.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA Cancer J. Clin. 71, 7–33 (2021).
Teloken, P. E. et al. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J. Urol. 182, 2132–2136 (2009).
Nguyen, D. P. et al. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy. Urol. Oncol. 34, 259.e1–259.e8 (2016).
Cheaib, J. G. et al. Stage-specific conditional survival in renal cell carcinoma after nephrectomy. Urol. Oncol. 38, 6.e1–6.e7 (2020).
Rosiello, G. et al. Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma. Urol. Oncol. https://doi.org/10.1016/j.urolonc.2021.12.010 (2022).
Kriegmair, M. C. et al. Systematic review of the management of local kidney cancer relapse. Eur. Urol. Oncol. 1, 512–523 (2018).
All, S., Garant, A. & Hannan, R. Stereotactic ablative radiation (SAbR) for oligometastatic RCC. Semin. Radiat. Oncol. 31, 227–234 (2021).
Choueiri, T. K. et al. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. N. Engl. J. Med. 385, 683–694 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Gerald, T., Margulis, V. Variability in prognostic models for localized renal cell carcinoma. Nat Rev Urol 19, 385–386 (2022). https://doi.org/10.1038/s41585-022-00590-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-022-00590-5